Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“Sell the news”
Then you don’t know the long term goal here is to sell the company? Obviously Sarissa is in it for themselves. You sell the news ASV along come huge news and you’re trying to buy back in at a much higher price. Just buy as much as you can as low as you can and hold on.
https://www.cnbc.com/2024/06/10/fda-advisors-recommend-eli-lilly-alzheimers-drug-donanemab.html
New plaque reducing Alzheimer’s drug.
Thanks
I can’t see the “25% reduction” for some reason. Could you copy and paste it?
It’s probablyBS. Yahoo is not the best source of facts.
Yahoo has a post that Roaring Kitty likes Amarin.
How long do these decisions normally take?
Their exposure is due to their promoting the intent to violate the skinny label ruling.
They are toast.
Anyone listening on the JP Morgan presentation? Any unusual news? Not seeing an aftermarket jump.
It didn’t work for a buddy of mine. Very professional guy. Fought off GV a couple times then decided he’d see what happened. His triglycerides went back up on GV. Switched back to real Vascepa and his triglycerides are back down.
No I’m not lying.
Any idea how long it takes to escort the parasites out the door and seat the replacements?
I read somewhere that we were approved in Hong Kong? This true?
The Bakers just got screwed on Kodiak. It’ll be in the top 5 of their losses….all time.
369151. The link
Vivus didn’t either. I had that one too. Science was decent but not a game changer. The issue there (I think) is you couldn’t get a Doc to think Vivus was better than exercise.
Vascepa is a game changer.
Same here. Obviously the stocks in my biotech portfolio are out of favor.
I thought Jessellivermore hedged his entire position at $18? Cost him $100K+ to do it.
Wise move….wish I had done it.
If Pfizer’s Covid pill will handle this new variant we are fine. Should be widely distributed in a couple months.
The market is way inflated (except AMRN). Way overdue for a sell off. The President is experiencing the most negative rating in history. Doesn’t make sense for the market to setting records.
At $4 and change…..Sarissa is still buying. Count on it.
Not sure what your first sentence is trying to say. Venbio did overhaul the board and oust the ceo. That may not be necessary here.
As far as infringement goes…..if AMRN is successful at pinning the generics to their skinny label we are fine. So far they are doing a decent job of that. If Glaxo prevails over TEVA it will be helpful.
So…..how about a 5 bagger? That good enough for you?
Last activist investor deal I was in was Immunomedics. CEO was trying to sell out too cheap. Venbio ousted him and we got sold to Gilead for $88. Easy 10 bagger.
My BO guess at $41? Tenbagger. I remember there was a pop on the Venbio news….then it traded sideways for a bit.
So….buy all you can right now. I’m well over 200K shares now.
https://www.biopharmadive.com/news/immunomedics-venbio-activist-lawsuit-seattle-genetics-deal/436344/
Swing and a miss MRC.
How about picking tomorrow’s close?
I agreed with this when I read it. Expected it to be nothing. I’ve let some folks know that today is the day.
I think that Amarin is in the camp of “get rid of the retail investors”. I can’t explain why they would’ve kept a leaky lid on the results to release them at a medical conference.
Expect to see the bottom today.
I’m not paying close attention but my takeaway is we spent a couple cents per share more than we took in….on a cash basis. Severances were part of it.
Doubt it…but I guess we will see.
Exactly what I was thinking. I don’t like that the market in the USA is stagnant but it is holding and pretty much break even at this point. Should turn a profit next quarter. This report is sort of a “meh”. No reason to go down. If we sell off at the open there may be several folks buying in. I personally know two guys that are waiting for what they think is the bottom to double up their shares.
I won’t. All it takes as a few more of us to spoil the party.
YMB poster that seems legit says Jeffries reducing PT of $6 to $5.
No one else can find it.
Good….that’s how it should be.
Isn’t the incentive given to all employees…..vaccinated or not?
Get ready……
I didn’t buy 5K today. Would have to sell something else to do it.
Hopefully not buying today will be a huge mistake.
Patience grasshopper.
It’s nonsensical as it makes no sense. He has a PT at $5. Stock is trading significantly under $5. He rates it a sell.
It’s nonsense.
Anyone with a brain should disregard it as nonsense.
So…there’s an agenda. Which is the one I stated that you agreed with.
A sell rating with a PT that’s significantly higher than where are currently trading is nonsensical. It’s just past of the scheme to drive retail nuts. Either to sell or vote in favor of a buyout. Last I checked retail still had the ability to vote yes or no. Takes 75% to vote in favor for a BO to succeed.
It’s a Honda powered deal that vaporizes the solution. 95%+ oil. Permethrin is the bug killer in it but it’s diluted pretty good. Every now and then I have to run thru the fog. It hangs in the air for quite a while. 2 gallons will make 10-12 runs around the grounds. It’s mounted in the back of a can am 6x6. Been doing it for 15 years.
Gotta die of something. Bugs would’ve killed me by now if I let them.
Lemm…..Why not Moderna?
Exam77
From Amarin:
It is our understanding that the Independent Investigator Sponsored study, PREPARE-IT 1, was accepted as a Late Breaker for presentation at the upcoming European Society of Cardiology in late August. Amarin does not have the data as the Company did not conduct the study. We will see the data when it is released at the Congress meeting.
Thank you for your inquiry.
Sincerely,
Investor Relations
Amarin Corp.